期刊文献+

血液透析患者猝死原因的临床分析 被引量:3

血液透析患者猝死原因的临床分析
下载PDF
导出
摘要 目的:分析血液透析患者猝死的相关性因素,以更好的防治血液透析患者的猝死。方法:回顾血液透析室具有完整病历资料的死亡患者57例,其中猝死18例,对比分析猝死患者(猝死组)和其他死亡患者(非猝死组)死亡前3个月的临床、实验室相关资料及回访1年内的心脏彩超结果,以猝死为因变量对上述资料进行逐步多元回归分析。结果:维持透析时间长短、死亡前1个月的平均透析前血压控制情况、透析间期体重及平均每次超滤量猝死组均高于非猝死组、每周透析时间<8小时、高钾血症及合并糖尿病在猝死组的比例显著高于非猝死组。猝死组与非猝死组之间的比较,P值<0.05差异有统计学意义,与血液透析患者的猝死有关。糖尿病、维持透析时间、透析前血压增高、每周透析时间<8小时、透析间期体重增加过多、高钾血症是血液透析患者猝死的独立危险因素。结论:维持透析时间长、合并糖尿病、透析间期体重增加过多、血压控制差及透析不充分是血液透析患者猝死的危险因素。 Objective:To analyse the cause of sudden death in hemodialysis patients, and prevention and controll sudden death. Meth- ods:A retrospective analysis of our hemodi- alysis room 4years, with more complete med- ical records of 57 cases of patients, which meet the standards of the 18 cases of sudden death. Comparative Analysis of sudden death (SD group)and other patients who died (non - sudden death group ) died before 3 months of clinical,laboratory data and death of the fist 1 year of echocardiography re- sults. To sudden death as the dependent var- iable on the clinical data stepwise multiple regression analysis. Results:Sudden death inpatients ! month before death, the average blood pressure before dialysis, the average for each ultrafihration dialysis and maintain dialysis time were significantly higher than non - sudden death group. Sudden death in patients with diabetes, the weekly dialysis time was less 8 hours and hyperkalemia, sig- nificantly higher than the proportion of pa- tients with non - sudden death group. Multi- ple regression analysis showed that diabetes mellitus,blood pressure increased, the aver- age dialysis ultrafiltration, maintain dialysis time, and less than 8 hours per week dial- ysied was hemodialysied patients with risk factors for sudden death. Conclusions: Dia- betes, long maintain dialysis time, poor blood pressure control, volume overload, and inadequate dialysis are hemodialysis patients risk factors for sudden death.
出处 《中国社区医师(医学专业)》 2012年第18期89-91,共3页
关键词 血液透析 猝死 临床分析 Hemodialysis Sudden death Risk factors Clinical analysis
  • 相关文献

参考文献10

  • 1Herzog CA.Cardiac arrest in dialysis patients:Approaches to alter an abysmal outcome[J].Kidney Int,2003,184:197-200.
  • 2Kai Ming Chow,Cheuk Chun Szeto,Bonnie Ching-Ha Kwan,et al.Factors Associated with Sudden Death in Peritoneal Dialysis Patients[J].Peritoneal Dialysis International,2008,29(1):58-60.
  • 3US Renal Data System:USRDS 2006 Annual Data Report.National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases[J].Bethesda,MD,2006.
  • 4Bleyer AJ,Russell GB,Satko SG.Sudden and cardiac death rates in hemodialysis patients[J].Kidney Int,1999,55:1553-1559.
  • 5甘良英,王梅.血液透析患者心脏性猝死的流行病学及其特点[J].中国血液净化,2007,6(4):178-179. 被引量:7
  • 6Ifudu O,Reydel K,Vlacich V,et al.Dietary potassium is not the sole determinant of serum potassium concentration in hemodialysis patients.Dial Transplantant,2004,33:684-693.
  • 7Bleyer AJ,J Hartman,PC Brannon,et al.Characteristics of sudden death in hemodialysis patients.Kidney Int,2006,69:2268-2273.
  • 8张彤,程滨,梅长林.血液透析患者心源性猝死的原因及预防[J].中国血液净化,2008,7(1):33-34. 被引量:3
  • 9Cice G,Ferrara L,D Andrea A,et al.Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial[J].J Am Coll Cardiol,2003,41:1438-1444.
  • 10Zannad F,Kessler M,Lehert P,et al.Prevention of cardiovascular events in end-stage renal disease:results of a randomized trial of fosinopril and implication for future studies[J].Kidney Int,2006,70:1318-1324.

二级参考文献15

  • 1US Renal Data System:USRDS 2006 Annual Data Report.National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases[J].Bethesda,MD,2006.
  • 2Bleyer AJ,Russell GB,Satko SG.Sudden and cardiac death rates in hemodialysis patients[J].Kidney Int,1999,55:1553-1559.
  • 3Tada T,Kusano KF,Ogawa A,et al.The predictors of central and obstructive sleep apnoea in haemodialysis patients[J].Nephrol Dial Transplant,2007,22:1190-1197.
  • 4Chakravorty I,Shastry M,Farrington K.Sleep apnoea in end-stage renal disease:a short review of mechanisms and potential benefit from its treatment[J].Nephrol Dial Transplant,2007,22:28-31.
  • 5K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients[J].Am J Kidney Dis,2005,45:S1.
  • 6Karnik JA,Young BS,Lew NL,et al.Cardiac arrest and sudden death in dialysis units[J].Kidney Int,2001,60:350-357.
  • 7Cice G,Ferrara L,D'Andrea A,et al.Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy:a prospective,placebo-controlled trial[J].J Am Coll Cardiol,2003,41:1438-1444.
  • 8Efrati S,Zaidenstein R,Dishy V,et al.ACE inhibitors and survival of hemodialysis patients[J].Am J Kidney Dis,2002,40:1023-1029.
  • 9Takahashi A,Takase H,Toriyama T,et al.Candesartan,an angiotensin Ⅱ type-1 receptor blocker,reduces cardiovascular events in patients on chronic haemodialysisa randomized study[J].Nephrol Dial Transplant,2006,21:2507-2012.
  • 10Zannad F,Kessler M,Lehert P,et al.Prevention of cardiovascular events in end-stage renal disease:results of a randomized trial of fosinopril and implications for future studies[J].Kidney Int,2006,70:1318-1324.

共引文献7

同被引文献52

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部